Injectable GHK-Cu is classified by the FDA as a Category 2 substance, which restricts its compounding at 503A pharmacies, and it is not FDA-approved for any indication
Crystal clear solution is the goal
Nat Rev Neurosci
Standard Dosing Range Most users find therapeutic benefit with daily doses between 0.25mg and 0.5mg
14: Bajramagic S, Sever M, Rasic F, Staresinic M, Skrtic A, Beketic Oreskovic L, Oreskovic I, Strbe S, Loga Zec S, Hrabar J, Coric L, Prenc M, Blagaic V, Brcic K, Boban Blagaic A, Seiwerth S, Sikiric P
published in the Journal of Applied Physiology confirmed that BPC-157 significantly accelerated outgrowth of Achilles tendon explants, markedly increased in vitro tendon fibroblast migration in a dose-dependent manner, and substantially increased fibroblast survival under HO-induced oxidative stress establishing a three-part cellular mechanism (outgrowth, migration, survival) that distinguishes BPC-157s tendon repair profile from direct mitogenic agents